We are live on
!
Find out more
Protagonist Therapeutics
PTGX
PTGX
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JGC
151
J. Goldman & Co
New York
| – | -$897K | -19,986 | Closed |
|
152
Principal Financial Group
Des Moines,
Iowa
| – | -$743K | -16,540 | Closed |
|
|
KAS
153
Kestra Advisory Services
Austin,
Texas
| – | -$626K | -13,939 | Closed |
|
|
AB
154
Amalgamated Bank
New York
| – | -$350K | -7,807 | Closed |
|
|
WG
155
Winton Group
London,
United Kingdom
| – | -$244K | -5,431 | Closed |
|
|
SSA
156
Schonfeld Strategic Advisors
New York
| – | -$224K | -5,000 | Closed |
|
|
GAM
157
Gotham Asset Management
New York
| – | -$215K | -4,793 | Closed |
|
|
EGM
158
Engineers Gate Manager
New York
| – | -$211K | -4,710 | Closed |
|
|
FC
159
FORA Capital
Miami,
Florida
| – | -$123K | -2,731 | Closed |
|
|
HFM
160
Hartford Financial Management
Hartford,
Connecticut
| – | -$13K | -300 | Closed |
|
|
SOW
161
State of Wyoming
Cheyenne,
Wyoming
| – | -$4.05K | -95 | -79% |
|
|
EI
162
Ellevest Inc
New York
| – | +$256 | +6 | New |
|